AstraZeneca
AstraZeneca
AstraZeneca Joins Obesity Market with $30m Investment
📢 Swiss obesity start-up SixPeaks Bio secures $30m, partners with AstraZeneca to develop potential obesity treatment. 💪💊🍔 ObesityMarket Collaboration
AstraZeneca Buys Fusion Therapeutics for $2 Billion Revolutionizing Cancer Treatment
🔬 AstraZeneca is acquiring Fusion Therapeutics Inc for $2 billion upfront to transform cancer treatment with targeted therapies. 💰🌟
AstraZeneca Acquires Amolyt Pharma for $105bn!
📢 AstraZeneca to acquire Amolyt Pharma for $1.05bn 💼💰 with $800m upfront and potential milestone payments of $250m. Amazing news for biotech in France and Europe!
AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible
📢 AstraZeneca teams up with FasTCAR to fast-track cell therapy production, revolutionizing accessibility and affordability for patients. 🚀
AstraZeneca’s $300M Expansion Ignites Cell and Gene Therapy Revolution
AstraZeneca invests $300m in new research facility in Cambridge, UK to advance cell and gene therapies. 💉🔬💼🔍👥
AstraZeneca Seeks UK Gov Aid to Boost Vaccine Production
📰 AstraZeneca wants UK Gov aid to expand vaccine plant 💸 The pharmaceutical company seeks financial support to boost production capacity. 💉
Revolutionary RSV Treatment Approved in China!
📝 AZ's Beyfortus authorized as first RSV treatment in China! 💊🇨🇳 Significant breakthrough in biotech industry. 👏😃
AstraZeneca’s Big Cell Therapy Breakthrough: Gracell Acquisition
📢 AstraZeneca accelerates cell therapy ambitions through Gracell buy 🌱 Expanding capabilities, boosting oncology portfolio, and driving scientific innovation. 💪🏢🌍
AstraZeneca’s $12bn Chinese Biotech Power Move
🌍💊 AstraZeneca boosts cell therapy projects by acquiring Gracell Biotechnologies for $1.2bn to fight cancer and autoimmune diseases. 🦠🚀 Expected to close Q1 2024.
